Multicancer Tests, Presbyopia Eye Drops, Workforce Trends, and Dementia Risk in Kids
Update: 2025-09-16
Description
In this episode, Dr. Chi-Ming Chow explores multicancer detection tests, assessing their reviews, accuracy, and future research. He discusses studies on presbyopia eye drops, focusing on pilocarpine and diclofenac, their safety, and approval. The episode also covers healthcare workforce trends, insights from a Harris Poll on job satisfaction, and AI-driven retention strategies. Dr. Chow examines hormone therapy's impact on cardiovascular risks in older women and the link between childhood loneliness and dementia risk. He also provides insights on urinary retention and enhancing patient satisfaction through improved discharge processes.
(0:00 ) Welcome and introduction
(0:28 ) Multicancer detection tests: Reviews, accuracy, utility, and future research
(3:50 ) Eye drops for presbyopia: Pilocarpine and diclofenac studies, safety, and approvals
(8:23 ) Healthcare workforce trends: Harris Poll survey, job satisfaction, and AI retention strategies
(12:00 ) Hormone therapy and cardiovascular risks in older women
(16:13 ) Childhood loneliness linked to dementia risk
(19:47 ) Understanding and treating urinary retention
(23:09 ) Patient satisfaction and improving the discharge process
(0:00 ) Welcome and introduction
(0:28 ) Multicancer detection tests: Reviews, accuracy, utility, and future research
(3:50 ) Eye drops for presbyopia: Pilocarpine and diclofenac studies, safety, and approvals
(8:23 ) Healthcare workforce trends: Harris Poll survey, job satisfaction, and AI retention strategies
(12:00 ) Hormone therapy and cardiovascular risks in older women
(16:13 ) Childhood loneliness linked to dementia risk
(19:47 ) Understanding and treating urinary retention
(23:09 ) Patient satisfaction and improving the discharge process
Comments
In Channel























